CCYG

 
Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • 14205 SE 36th Street
  • Suite 100
  • Bellevue, WA 98006

  • Phone: (425) 519-3755
Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2014 10-Q
CIK 0001325279
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. 2004
Employees Not Available
Company Officers/Contacts
John A. Fluke Interim CEO
Douglas A. Cerretti President
Randy Lieber CFO
Dr. Theresa A Deisher VP, R&D
Dr. Jeffrey Solash Business Affairs
Company Directors
Robert Harris
Randy Lieber
Company Notes
  • Formerly=Shepard, Inc. until 2-07
  • Note=9-30-05 company is in the exploration stage
Service Providers
Accounting/Auditing Firm
Fruci & Associates, PLLC
218 North Bernard
Second Floor
Spokane, WA, 99210
United States

Legal Counsel
Parsons / Burnett / Bjordahl / Hume, LLP
10655 NE 4th St.
Suite 801
Bellevue, WA, 98004
United States

Investor Relations Firm
Not Available
CCYG Security Details
Share Structure
Market Value1 $164,659 a/o Dec 07, 2016
Authorized Shares Not Available
Outstanding Shares 82,329,481 a/o Aug 16, 2013
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Transfer Agent(s)
Island Stock Transfer
Shareholders
Shareholders of Record 154 a/o Apr 12, 2013
Short Selling Data
Short Interest 1,507 (100%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security